Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
EPSN vs REPX vs CIVI vs GRNT vs TPVG
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
Oil & Gas Exploration & Production
Asset Management
EPSN vs REPX vs CIVI vs GRNT vs TPVG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Oil & Gas Exploration & Production | Asset Management |
| Market Cap | $130M | $743M | $2.34B | $737M | $243M |
| Revenue (TTM) | $46M | $403M | $4.71B | $327M | $97M |
| Net Income (TTM) | $6M | $62M | $638M | $-32M | $-12M |
| Gross Margin | 47.6% | 63.5% | 43.9% | 19.6% | 83.5% |
| Operating Margin | 21.9% | 32.1% | 31.1% | 19.4% | 77.9% |
| Forward P/E | 17.3x | 6.4x | 6.8x | 8.7x | 6.5x |
| Total Debt | $477K | $255M | $4.49B | $18M | $469M |
| Cash & Equiv. | $7M | $18M | $76M | $15M | $20M |
EPSN vs REPX vs CIVI vs GRNT vs TPVG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Epsilon Energy Ltd. (EPSN) | 100 | 179.8 | +79.8% |
| Riley Exploration P… (REPX) | 100 | 241.6 | +141.6% |
| Civitas Resources, … (CIVI) | 100 | 122.7 | +22.7% |
| Granite Ridge Resou… (GRNT) | 100 | 57.0 | -43.0% |
| TriplePoint Venture… (TPVG) | 100 | 46.5 | -53.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EPSN vs REPX vs CIVI vs GRNT vs TPVG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EPSN ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.15, Low D/E 0.5%, current ratio 2.02x
- Beta 0.15, yield 4.3%, current ratio 2.02x
- Beta 0.15 vs CIVI's 1.10, lower leverage
REPX carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 183.6% 10Y total return vs EPSN's -66.9%
- 4.6% yield, 5-year raise streak, vs CIVI's 18.2%
- +43.9% vs EPSN's -4.7%
- 5.4% ROA vs GRNT's -3.8%, ROIC 12.9% vs 9.5%
CIVI is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 49.8%, EPS growth -6.2%, 3Y rev CAGR 77.5%
- PEG 0.32 vs TPVG's 6.41
- 49.8% revenue growth vs REPX's -4.4%
- PEG 0.32 vs 6.41
GRNT is the clearest fit if your priority is income & stability.
- Dividend streak 3 yrs, beta 0.41, yield 7.9%
TPVG is the clearest fit if your priority is quality.
- 50.6% margin vs GRNT's -9.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 49.8% revenue growth vs REPX's -4.4% | |
| Value | PEG 0.32 vs 6.41 | |
| Quality / Margins | 50.6% margin vs GRNT's -9.9% | |
| Stability / Safety | Beta 0.15 vs CIVI's 1.10, lower leverage | |
| Dividends | 4.6% yield, 5-year raise streak, vs CIVI's 18.2% | |
| Momentum (1Y) | +43.9% vs EPSN's -4.7% | |
| Efficiency (ROA) | 5.4% ROA vs GRNT's -3.8%, ROIC 12.9% vs 9.5% |
EPSN vs REPX vs CIVI vs GRNT vs TPVG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
EPSN vs REPX vs CIVI vs GRNT vs TPVG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CIVI leads in 1 of 6 categories
EPSN leads 0 • REPX leads 0 • GRNT leads 0 • TPVG leads 0 • 5 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — EPSN and TPVG each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
CIVI is the larger business by revenue, generating $4.7B annually — 102.9x EPSN's $46M. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to GRNT's -9.9%. On growth, EPSN holds the edge at +23.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $46M | $403M | $4.7B | $327M | $97M |
| EBITDAEarnings before interest/tax | $22M | $229M | $3.4B | $231M | -$22M |
| Net IncomeAfter-tax profit | $6M | $62M | $638M | -$32M | -$12M |
| Free Cash FlowCash after capex | $10M | $68M | $934M | -$39M | $35M |
| Gross MarginGross profit ÷ Revenue | +47.6% | +63.5% | +43.9% | +19.6% | +83.5% |
| Operating MarginEBIT ÷ Revenue | +21.9% | +32.1% | +31.1% | +19.4% | +77.9% |
| Net MarginNet income ÷ Revenue | +12.9% | +15.3% | +13.6% | -9.9% | +50.6% |
| FCF MarginFCF ÷ Revenue | +22.7% | +16.9% | +19.8% | -12.0% | -58.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +23.2% | +11.2% | -8.1% | -100.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | -3.5% | -33.9% | -5.8% | -2.3% |
Valuation Metrics
CIVI leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 3.2x trailing earnings, CIVI trades at a 95% valuation discount to EPSN's 66.9x P/E. Adjusting for growth (PEG ratio), CIVI offers better value at 0.15x vs TPVG's 4.84x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $130M | $743M | $2.3B | $737M | $243M |
| Enterprise ValueMkt cap + debt − cash | $124M | $980M | $6.8B | $740M | $691M |
| Trailing P/EPrice ÷ TTM EPS | 66.89x | 4.51x | 3.24x | 31.06x | 4.91x |
| Forward P/EPrice ÷ next-FY EPS est. | 17.29x | 6.41x | 6.75x | 8.73x | 6.50x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.15x | — | 4.84x |
| EV / EBITDAEnterprise value multiple | 9.09x | 4.18x | 1.89x | 2.41x | 9.13x |
| Price / SalesMarket cap ÷ Revenue | 4.11x | 1.89x | 0.45x | 1.64x | 2.50x |
| Price / BookPrice ÷ Book value/share | 1.33x | 1.14x | 0.41x | 1.20x | 0.68x |
| Price / FCFMarket cap ÷ FCF | — | 8.61x | 2.61x | — | — |
Profitability & Efficiency
Evenly matched — EPSN and REPX each lead in 5 of 9 comparable metrics.
Profitability & Efficiency
REPX delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-5 for GRNT. EPSN carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to TPVG's 1.33x. On the Piotroski fundamental quality scale (0–9), EPSN scores 6/9 vs TPVG's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.9% | +10.7% | +9.5% | -5.3% | -3.4% |
| ROA (TTM)Return on assets | +4.7% | +5.4% | +4.2% | -3.8% | -1.5% |
| ROICReturn on invested capital | +2.9% | +12.9% | +10.8% | +9.5% | +7.2% |
| ROCEReturn on capital employed | +3.0% | +15.0% | +12.1% | +9.0% | +9.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.40x | 0.68x | 0.03x | 1.33x |
| Net DebtTotal debt minus cash | -$6M | $237M | $4.4B | $3M | $449M |
| Cash & Equiv.Liquid assets | $7M | $18M | $76M | $15M | $20M |
| Total DebtShort + long-term debt | $476,911 | $255M | $4.5B | $18M | $469M |
| Interest CoverageEBIT ÷ Interest expense | 157.74x | 5.60x | 2.80x | 7.13x | -1.02x |
Total Returns (Dividends Reinvested)
Evenly matched — EPSN and REPX each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EPSN five years ago would be worth $17,622 today (with dividends reinvested), compared to $7,297 for GRNT. Over the past 12 months, REPX leads with a +43.9% total return vs EPSN's -4.7%. The 3-year compound annual growth rate (CAGR) favors EPSN at 8.5% vs CIVI's -16.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +29.2% | +31.7% | -1.5% | +21.8% | -6.3% |
| 1-Year ReturnPast 12 months | -4.7% | +43.9% | +6.8% | +21.3% | +19.3% |
| 3-Year ReturnCumulative with dividends | +27.8% | -8.8% | -41.7% | +15.0% | -3.4% |
| 5-Year ReturnCumulative with dividends | +76.2% | +20.4% | +31.9% | -27.0% | -13.5% |
| 10-Year ReturnCumulative with dividends | -66.9% | +183.6% | -86.2% | -28.5% | +93.3% |
| CAGR (3Y)Annualised 3-year return | +8.5% | -3.0% | -16.5% | +4.8% | -1.2% |
Risk & Volatility
Evenly matched — EPSN and REPX each lead in 1 of 2 comparable metrics.
Risk & Volatility
EPSN is the less volatile stock with a 0.15 beta — it tends to amplify market swings less than CIVI's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. REPX currently trades 83.5% from its 52-week high vs EPSN's 69.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.15x | 0.47x | 1.10x | 0.41x | 0.83x |
| 52-Week HighHighest price in past year | $8.50 | $40.98 | $37.45 | $6.72 | $7.53 |
| 52-Week LowLowest price in past year | $4.20 | $24.08 | $25.38 | $4.18 | $4.48 |
| % of 52W HighCurrent price vs 52-week peak | +69.2% | +83.5% | +73.1% | +83.2% | +79.5% |
| RSI (14)Momentum oscillator 0–100 | 44.5 | 40.3 | 54.8 | 51.2 | 58.3 |
| Avg Volume (50D)Average daily shares traded | 246K | 457K | 22.4M | 955K | 504K |
Analyst Outlook
Evenly matched — REPX and CIVI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: REPX as "Buy", CIVI as "Hold", GRNT as "Hold", TPVG as "Hold". Consensus price targets imply 49.4% upside for TPVG (target: $9) vs 8.1% for REPX (target: $37). For income investors, CIVI offers the higher dividend yield at 18.19% vs EPSN's 4.25%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $8.40 | $37.00 | $31.00 | — | $8.95 |
| # AnalystsCovering analysts | — | 3 | 16 | 3 | 12 |
| Dividend YieldAnnual dividend ÷ price | +4.3% | +4.6% | +18.2% | +7.9% | +17.1% |
| Dividend StreakConsecutive years of raises | 1 | 5 | 0 | 3 | 0 |
| Dividend / ShareAnnual DPS | $0.25 | $1.57 | $4.98 | $0.44 | $1.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +0.4% | +18.3% | +0.0% | 0.0% |
CIVI leads in 1 of 6 categories — strongest in Valuation Metrics. 5 categories are tied.
EPSN vs REPX vs CIVI vs GRNT vs TPVG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EPSN or REPX or CIVI or GRNT or TPVG a better buy right now?
For growth investors, Civitas Resources, Inc.
(CIVI) is the stronger pick with 49. 8% revenue growth year-over-year, versus -4. 4% for Riley Exploration Permian, Inc. (REPX). Civitas Resources, Inc. (CIVI) offers the better valuation at 3. 2x trailing P/E (6. 8x forward), making it the more compelling value choice. Analysts rate Riley Exploration Permian, Inc. (REPX) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EPSN or REPX or CIVI or GRNT or TPVG?
On trailing P/E, Civitas Resources, Inc.
(CIVI) is the cheapest at 3. 2x versus Epsilon Energy Ltd. at 66. 9x. On forward P/E, Riley Exploration Permian, Inc. is actually cheaper at 6. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Civitas Resources, Inc. wins at 0. 32x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EPSN or REPX or CIVI or GRNT or TPVG?
Over the past 5 years, Epsilon Energy Ltd.
(EPSN) delivered a total return of +76. 2%, compared to -27. 0% for Granite Ridge Resources, Inc (GRNT). Over 10 years, the gap is even starker: REPX returned +183. 6% versus CIVI's -86. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EPSN or REPX or CIVI or GRNT or TPVG?
By beta (market sensitivity over 5 years), Epsilon Energy Ltd.
(EPSN) is the lower-risk stock at 0. 15β versus Civitas Resources, Inc. 's 1. 10β — meaning CIVI is approximately 628% more volatile than EPSN relative to the S&P 500. On balance sheet safety, Epsilon Energy Ltd. (EPSN) carries a lower debt/equity ratio of 0% versus 133% for TriplePoint Venture Growth BDC Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — EPSN or REPX or CIVI or GRNT or TPVG?
By revenue growth (latest reported year), Civitas Resources, Inc.
(CIVI) is pulling ahead at 49. 8% versus -4. 4% for Riley Exploration Permian, Inc. (REPX). On earnings-per-share growth, the picture is similar: Riley Exploration Permian, Inc. grew EPS 78. 2% year-over-year, compared to -71. 6% for Epsilon Energy Ltd.. Over a 3-year CAGR, CIVI leads at 77. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EPSN or REPX or CIVI or GRNT or TPVG?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus 5. 4% for Granite Ridge Resources, Inc — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus 10. 9% for EPSN. At the gross margin level — before operating expenses — TPVG leads at 83. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EPSN or REPX or CIVI or GRNT or TPVG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Civitas Resources, Inc. (CIVI) is the more undervalued stock at a PEG of 0. 32x versus TriplePoint Venture Growth BDC Corp. 's 6. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Riley Exploration Permian, Inc. (REPX) trades at 6. 4x forward P/E versus 17. 3x for Epsilon Energy Ltd. — 10. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 49. 4% to $8. 95.
08Which pays a better dividend — EPSN or REPX or CIVI or GRNT or TPVG?
All stocks in this comparison pay dividends.
Civitas Resources, Inc. (CIVI) offers the highest yield at 18. 2%, versus 4. 3% for Epsilon Energy Ltd. (EPSN).
09Is EPSN or REPX or CIVI or GRNT or TPVG better for a retirement portfolio?
For long-horizon retirement investors, Epsilon Energy Ltd.
(EPSN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 15), 4. 3% yield). Both have compounded well over 10 years (EPSN: -66. 9%, CIVI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EPSN and REPX and CIVI and GRNT and TPVG?
These companies operate in different sectors (EPSN (Energy) and REPX (Energy) and CIVI (Energy) and GRNT (Energy) and TPVG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EPSN is a small-cap income-oriented stock; REPX is a small-cap deep-value stock; CIVI is a small-cap high-growth stock; GRNT is a small-cap high-growth stock; TPVG is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.